UnitedHealth sinks on WSJ report of DoJ launching probe into Medicare practices

Investing.com
21 Feb

Investing.com -- The US Justice Department (DoJ) has opened a civil fraud investigation into UnitedHealth’s Medicare billing practices in recent months, the Wall Street Journal (WSJ) reported on Friday, citing sources with knowledge of the matter.

UnitedHealth (NYSE:UNH) shares sank roughly 10% in premarket trading following the report.

Per the report, the investigation is focused on how the company records diagnoses that increase Medicare payments to its Advantage plans, including at physician groups owned by UnitedHealth.

Last year, a series of WSJ reports revealed that Medicare had paid the company billions of dollars based on questionable diagnoses. The report noted that Justice Department attorneys interviewed medical providers named in the articles as recently as January 31.

Under the Medicare Advantage program, insurers receive fixed payments from the federal government to manage enrollees’ benefits. The reimbursement amounts increase when patients are diagnosed with specific conditions, creating a financial incentive for insurers to document more diagnoses.

The latest probe adds to growing scrutiny of UnitedHealth, a $400 billion company that operates the country’s largest health insurer along with a vast network of healthcare businesses, including physician groups, a pharmacy-benefit manager, and data and technology services.

This civil investigation is reportedly separate from the Justice Department’s ongoing antitrust probe into UnitedHealth, which the WSJ reported on last year. The DOJ has also sued to block the company’s $3.3 billion acquisition of home-health provider Amedisys (NASDAQ:AMED), citing antitrust concerns.

UnitedHealth has previously defended its Medicare billing practices, saying they improve diagnostic accuracy, comply with audits, and ultimately benefit patients.

In December, the WSJ reported that an analysis of billions of Medicare records showed a significant increase in high-value diagnoses for patients treated by UnitedHealth-employed physicians after joining the company’s Medicare Advantage plans.

Some doctors said the company trained them to document revenue-generating conditions, including those they felt were unnecessary or irrelevant. UnitedHealth also used software to suggest potential diagnoses and provided financial incentives to encourage their inclusion, according to the report.

Related Articles

UnitedHealth sinks on WSJ report of DoJ launching probe into Medicare practices

Holcim's North American business to be called Amrize after spin off

Slovak PM urges Musk to resist US tariffs on Europe

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10